A Single-center, Prospective,Randomized Study of Antiplatelet Effects of Ticagrelor Versus Clopidogrel in Patients With Dual Anti-platelet Therapy After Coronary Artery Bypass Grafting
Phase of Trial: Phase IV
Latest Information Update: 12 May 2017
At a glance
- Drugs Ticagrelor (Primary) ; Aspirin; Clopidogrel
- Indications Acute coronary syndromes
- Focus Therapeutic Use
- Acronyms ATCCC
- 06 May 2017 Status changed from recruiting to completed.
- 22 Aug 2016 Status changed from not yet recruiting to recruiting.
- 08 Jan 2015 New trial record